LivaNova PLC LIVN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/09/24 EDT
61.95UNCH (UNCH)
Volume
45,454
Close
61.95UNCH (UNCH)
Volume
458,941
52 week range
42.75 - 64.47
Loading...
  • Open62.70
  • Day High63.00
  • Day Low61.91
  • Prev Close61.95
  • 52 Week High64.47
  • 52 Week High Date05/06/24
  • 52 Week Low42.75
  • 52 Week Low Date12/05/23

Key Stats

  • Market Cap3.355B
  • Shares Out54.15M
  • 10 Day Average Volume0.94M
  • Dividend-
  • Dividend Yield-
  • Beta0.99
  • YTD % Change19.73

KEY STATS

  • Open62.70
  • Day High63.00
  • Day Low61.91
  • Prev Close61.95
  • 52 Week High64.47
  • 52 Week High Date05/06/24
  • 52 Week Low42.75
  • 52 Week Low Date12/05/23
  • Market Cap3.355B
  • Shares Out54.15M
  • 10 Day Average Volume0.94M
  • Dividend-
  • Dividend Yield-
  • Beta0.99
  • YTD % Change19.73

RATIOS/PROFITABILITY

  • EPS (TTM)-0.59
  • P/E (TTM)-104.80
  • Fwd P/E (NTM)21.47
  • EBITDA (TTM)138.312M
  • ROE (TTM)-2.59%
  • Revenue (TTM)1.185B
  • Gross Margin (TTM)67.89%
  • Net Margin (TTM)-2.67%
  • Debt To Equity (MRQ)51.12%

EVENTS

  • Earnings Date07/24/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On LivaNova PLC

 

Profile

MORE
LivaNova PLC is a medical technology company. The Company designs, develops, manufactures, markets and sells products and therapies. Its segments include Cardiopulmonary, Neuromodulation and Advanced Circulatory Support (ACS). Cardiopulmonary segment is engaged in the design, development, manufacture, marketing and selling of cardiopulmonary products, including heart-lung machines (HLM), oxygenators, autotransfusion systems, perfusion tubing systems, cannula and other related...
William Kozy
Chairman of the Board
Vladimir Makatsaria
Chief Executive Officer, Director
Alex Shvartsburg
Chief Financial Officer
Address
20 Eastbourne Terrace
London
W2 6LG
United Kingdom